Use of midodrine (Gutron) to treat permanent hypotension in a chronic hemodialysis patient

Clinical Nephrology

Volumn 56, Issue 2, 2001, Pages 162-168

  Montagnac, R ^a   Clavel, P ^a   Delhotal Landes, B ^a   Flouvat, B ^a   Poulain, S ^a   Schillinger, F ^a  

^a Troyes Hospital   (France)

Author keywords

Chronic hemodialysis; Hypotension; Midodrine

Indexed keywords

2 AMINO 1 (2,5 DIMETHOXYPHENYL)ETHANOL; ALPHA ADRENERGIC RECEPTOR; MIDODRINE;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CASE REPORT; CHRONIC DISEASE; CHRONIC KIDNEY FAILURE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG SAFETY; DRUG TOLERABILITY; DRUG USE; GASTROINTESTINAL DISEASE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HUMAN TISSUE; HYPERTENSION; HYPOTENSION; IRRITABILITY; MALE; PHYSICAL CAPACITY; PRURITUS; SIDE EFFECT; SKIN DISEASE; SYMPTOM; TABLET FORMULATION; TIME; URINE RETENTION; WELLBEING;

BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; HYPOTENSION; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MIDODRINE; RENAL DIALYSIS; VASOCONSTRICTOR AGENTS;

EID: 0034894878     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Midodrine efficacy and pharmacokinetics in a patient with recurrent intradialytic hypotension
2. Midodrine is effective and safe therapy for intradialytic hypotension over 8 months of follow-up
3. Intradialytic hypotension: Is midodrine beneficial in symptomatic hemodialysis patients?
4. Dialysis hypotension: A hemodynamic analysis
5. Preventing and managing hypotension
6. Studies on the peripheral hemodynamics in man after intravenous infusion of a small dose of (= ST 1085)
7. Midodrine hydrochloride in patients on hemodialysis with chronic hypotension
8. Midodrine treatment for patients with hemodialysis hypotension
9. A pilot evaluation of midodrine to treat patients with hemodialysis hypotension
10. Alpha-sympathomimetic treatment of autonomic insufficiency with orthostatic hypotension
11. Pharmacokinetic parameters and haemodynamic actions of midodrine in young volunteers
12. Treatment of dialysis-induced hypotension with L-threo-3,4-dihydroxy-phenylserine
13. Clinical effects of midodrine hydrochloride on orthostatic hypotension accompanying diabetes mellitus
14. Neurogenic orthostatic hypotension: A double-blind, placebo-controlled study with midodrine
15. Clinical evaluation of midodrine hydrochloride on hypotension related to hemodialysis in patients with chronic renal failure
16. Common clinical problems during hemodialysis
17. Treatment of orthostatic hypotension due to autonomic failure with a peripheral alpha-adrenergic agonist (midodrine)
18. A critical examination of dialysis-induced hypotension
19. Midodrine for the treatment of intradialytic hypotension
20. Orthostatic hypotension in the elderly
21. Controlled clinical investigation of dimetophrine versus midodrine in the management of moderately decreased arterial blood pressure
22. Diabetic autonomic neuropathy and cardiovascular risk
23. Midodrine: A review of its pharmacological properties and therapeutic use in orthostatic hypotension and secondary hypotensive disorders
24. Pharmacokinetic study of midodrine hydrochloride on renal and/or hepatic disorder
25. Dialysis hypotension: Do we see light at the end of the tunnel?
26. Midodrine: A new therapy for intradialytic hypotension
27. Pharmacodynamic actions of midodrine, a new alpha-adrenergic stimulating agent, and its main metabolite ST1059
28. A comparison of post-space flight orthostatic intolerance to vasovagal syncope and autonomic failure and the potential use of the alpha-agonist midodrine for these conditions
29. Midodrine: A new agent in the management of idiopathic orthostatic hypotension and Shy-Drager syndrome
30. The pathophysiologic basis for hemodialysis-related hypotension
31. The incidence of hypovolemic morbidity in hemodialysis
32. Vasoconstrictor effect of midodrine, ST 1059, noradrenaline, etilefrine and dihydro-ergotamine on isolated human veins
33. Clinical evaluation of midodrine hydrochloride on orthostatic syndrome - Study on optimal dose
34. Correction of severe orthostatic hypotension by midodrine: A new alpha-adrenoreceptor agonist
35. Effects of a α-adreno-receptor agonists on cardiac output and blood pressure in spinally anesthetized ganglion-blocked dogs
36. Pharmacodynamics of midodrine, an antihypotensive agent